Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology

Volumn 37, Issue 6, 1996, Pages 613-615

  Gridelli, Cesare ^a   Rossi, Antonio ^b   Incoronato, Pasquale ^b   Bruni, Giovanni Salvatore ^a   Scognamiglio, Francesco ^a   Ruffolo, Pasquale ^a   Rinaldi, Luciana ^a   Bianco, Angelo Raffaele ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Chemotherapy; Epirubicin; Ifosfamide; NSCLC

Indexed keywords

EPIRUBICIN; IFOSFAMIDE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HISTOLOGY; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIRUBICIN; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 0029987043     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050437     Document Type: Article

References (17)

1. Crinò L, Clerici M, Figoli F, Carlini P, Ceci G, Cortesi E, Carpi A, Santini A, Di Costanzo F, Boni C, Meacci M, Corgna E, Darwish S, Scarcella L, Santucci A, Tonato M (1995) Chemotherapy of advanced non small cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). Ann Oncol 6: 347-353
2. Eberhardt W, Niederle N (1992) Ifosfamide in non small cell lung cancer: a review. Semin Oncol 19 [Suppl 1]: 40-48
3. Feld R, Wierzbicki R, Walde D (1992) A phase I-II study of high dose epirubicin in advanced non small cell lung cancer. J Clin Oncol 10: 297-303
4. Frustaci S, Buonadonna A, Favaro D, Santarosa M, Quaia M, Galligioni E, Spada A, Lamon S, Monfardini S (1993) Epirubicin (EPI), ifosfamide (IFO) and GM-CSF in soft tissue sarcoma (STS) patients: feasibility of EPI escalating dose and evaluation of correlated blood CFU-GM. Proc Am Soc Clin Oncol 12: 469
5. Gridelli C, Pepe R, Palmeri S, Iacobelli S, Gentile M, Gebbia V, Garufi C, Airoma G, Palmieri G, Russo A, Incoronato P, De Placido S, Perrone F, Basilico L, Rausa L, Ferrante G, Bianco AR (1991) Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer. Cancer Chemother Pharmacol 28: 405-407
6. Gridelli C, De Placido S, Pepe R, Incoronato P, Airoma G, Rossi A, Palazzolo G, Bianco AR (1993) Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non small cell lung cancer. Eur J Cancer 29 A: 1729-1731
7. Joss RA, Hansen HH, Hansen M, Renards J, Rozencweig M (1984) Phase II trial of epirubicin in advanced squamous, adeno and large cell carcinoma of the lung. Eur J Clin Oncol 20: 495-499
8. Kosmidis P, Mylonakis N, Skareos DV, Samantas E, Beer M, Theocharis D, Zachariadis E, Gioti A, Papadakis E, Poulakis N, Parastatidis S, Fountzilas G (1994) A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non operable non small cell lung cancer. Ann Oncol 5: 159-162
9. Kris MG, Gralla RJ, Kelsen DP (1982) Trial of vindesine plus mitomycin in stage III non small cell lung cancer. An active regimen for out-patient treatment. Cancer Treat Rep 66: 1291-1297
10. Martoni A, Melotti B, Guaraldi M, Pannuti F (1991) Activity of high-dose epirubicin in advanced non small cell lung cancer. Eur J Cancer 27: 1231-1234
11. Martoni A, Guaraldi M, Casadio M, Busutti L, Pannuti F (1992) A phase II study of high-dose epirubicin plus cisplatin in advanced non small cell lung cancer. Ann Oncol 3: 864-866
12. Meyers FJ, Cardiff RD, Quadro R, Gribble M, Kohler M, Metrano U, Mitchell EP, Shiffman R, William L (1986) Epirubicin in non oat cell lung cancer - response rate and importance of immunopathology: a Northern California Oncology Group study. Cancer Treat Rep 70: 805-806
13. Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE (1992) A phase II study of high-dose epirubicin in unresectable non small cell lung cancer. Br J Cancer 65: 405-408
14. Smit EF, Piers DA, Postmus PE (1992) Phase II study of high-dose epirubicin and etoposide in advanced non small cell lung cancer. Eur J Cancer 28 A: 1963-1967
15. Toma S, Palumbo R, Canavese G (1993) Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas. Cancer Chemother Pharmacol 31 [Suppl 2]: S222-S227
16. Villar A, Anton E, Jimeno J (1991) Fractionated high-dose (HD) of epirubicin (E) in adenocarcinoma of the lung (ADL). Lung Cancer 7 [Suppl]: 122
17. Wils J, Utnama I, Sala L, Smeets J, Riva A (1990) A phase II study of high-dose epirubicin in non small cell lung cancer. Eur J Cancer 26: 1140-1141